Market Research Logo

Egypt Pharmaceuticals and Healthcare Report Q3 2015


Attention: There is an updated edition available for this report.

BMI View: The positive outlook for Egypt's pharmaceutical market has been reinforced, with access tomedicines increasing through enhancing health insurance uptake and a greater interest among foreignpharmaceutical companies. This represents an impressive turnaround, given the region's politicalinstability in recent years.

Headline Expenditure Projections

Pharmaceuticals: EGP23.03bn (USD3.25bn) in 2014 to EGP25.48bn (USD3.36bn) in 2015; +10.7% inlocal currency terms and 3.5% in US dollar terms. Forecast upgraded from Q215 following availability ofnew historic trade data.

Healthcare: EGP98.34bn (USD13.88bn) in 2014 to EGP107.69bn (USD14.21bn) in 2015; +9.5% inlocal currency terms and 2.4% in US dollar terms. Forecast broadly in line with Q215.


BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Egypt 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Egypt 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Egypt 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Egypt 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Egypt 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Egypt 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Egypt 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Egypt 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Egypt 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Egypt 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Macroeconomic Forecast
Expenditure Breakdown
Table: GDP By Expenditure (Egypt 2012-2019)
Industry Risk Reward Indices
Middle East And Africa Risk/Reward Index
Egypt Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Communicable Diseases
Non-Communicable Disease
Healthcare Sector
Private Healthcare Sector
Healthcare Financing
Healthcare Insurance
Table: Healthcare Resources (Egypt 2009-2014)
Table: Healthcare Personnel (Egypt 2009-2014)
Table: Healthcare Activity (Egypt 2009-2014)
Research & Development
Clinical Trials
Regulatory Development
Medicines Registration
Regional Harmonisation
Counterfeit Medicines
Intellectual Property
Pricing Regime
Reimbursement Regime
Watch List Status
Competitive Landscape
Pharmaceutical Industry
Table: HOLDIPHARMA's Joint Ventures, 2012
Domestic Pharmaceuticals Sector
Table: HOLDIPHARMA's Affiliated Companies, 2012
Table: HOLDIPHARMA's Financial Indicators, FY 2006/2007-FY2010/2011 (EGPmn)
Table: HOLDIPHARMA's Net Operating Revenue by Affiliate, FY 2010/2011 (EGPmn)
Table: Wholly Or Partially Owned Egyptian Pharmaceutical And Medical Device Companies By Parent Group
Foreign Pharmaceuticals Sector
Recent Industry Developments
Pharmaceutical Wholesale
Pharmaceutical Retail
Herbal And OTC Medicine
Company Profile
Egyptian International Pharmaceutical Industries Co (EIPICO)
South Egyptian Drug Industries (SEDICO)
Medical Union Pharmaceuticals (MUP)
Amoun Pharmaceutical Company (APC)
VACSERA
Misr Pharmaceuticals
GlaxoSmithKline
Sanofi
Pfizer
Novartis
Merck
AstraZeneca
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Egypt 1990-2025)
Table: Key Population Ratios (Egypt 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Egypt 1990-2025)
Table: Population By Age Group (Egypt 1990-2025)
Table: Population By Age Group % (Egypt 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report